I am a
Home I AM A Search Login

Papers of the Week


Ther Adv Musculoskelet Dis


Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study.


Varenna M, Braga V, Gatti D, Iolascon G, Frediani B, Zucchi F, Crotti C, Nannipieri F, Rossini M
Ther Adv Musculoskelet Dis. 2021; 13:1759720X211014020.
PMID: 34178124.


Complex regional pain syndrome type-1 (CRPS-1) is a severely disabling painful disease challenging to treat. This multicenter, randomized, double-blind placebo-controlled trial examined the efficacy of intramuscular (i.m.) neridronate in CRPS-1 patients.